KOPRAN
|
KOPRAN Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹68 Cr | ₹36 Cr | ₹82 Cr | ₹83 Cr | ₹29 Cr |
Adjustment | ₹21 Cr | ₹16 Cr | ₹14 Cr | ₹16 Cr | ₹22 Cr |
Changes In working Capital | ₹-31 Cr | ₹-5.55 Cr | ₹-111 Cr | ₹-24 Cr | ₹-12 Cr |
Cash Flow after changes in Working Capital | ₹58 Cr | ₹47 Cr | ₹-15 Cr | ₹76 Cr | ₹39 Cr |
Cash Flow from Operating Activities | ₹43 Cr | ₹34 Cr | ₹-33 Cr | ₹60 Cr | ₹31 Cr |
Cash Flow from Investing Activities | ₹-44 Cr | ₹-13 Cr | ₹-84 Cr | ₹-25 Cr | ₹-13 Cr |
Cash Flow from Financing Activities | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr | ₹-18 Cr |
Net Cash Inflow / Outflow | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr | ₹0.42 Cr |
Opening Cash & Cash Equivalents | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr | ₹0.41 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹8.09 Cr | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr |
Compare Cashflow Statement of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹929.8 Cr | -3.3% | 7.2% | -24.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,126.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,568.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹125,156.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,176.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,716.1 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -3.3% |
7.2% |
-24.5% |
SENSEX | 0.2% |
2.9% |
8.7% |
You may also like the below Video Courses